Boston, MA -- (SBWIRE) -- 01/03/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Energy XXI (Bermuda) Limited(NASDAQ:EXXI), Aruba Networks, Inc.(NASDAQ:ARUN), ZIOPHARM Oncology Inc.(NASDAQ:ZIOP), Select Medical Holdings Corporation(NYSE:SEM).
Energy XXI (Bermuda) Limited(NASDAQ:EXXI) opened its shares at the price of $26.98 for the day. Its closing price was $26.13 after losing -3.44% for the day. The company traded with the total volume of 1.31 million shares, while its average trading volume remained 1.45 million shares. The beta of EXXI stands at 2.02. Energy XXI (Bermuda) Limited (Energy XXI) is an independent oil and natural gas exploration and production company with operations focused in the United States Gulf Coast and the Gulf of Mexico.
Has EXXI Found The Bottom and Ready To Move Up? Find Out Here
Aruba Networks, Inc.(NASDAQ:ARUN) percentage change plunged -3.30% to close at $17.31 with the total traded volume of 1.44 million shares, and average volume of 2.40 million. The 52 week range of the stock remained $12.38 - $26.78, while its day lowest price was $17.20 and it hit its day highest price at $17.80. Aruba Networks, Inc., is a provider of next-generation network access solutions for mobile enterprise networks. The Mobile Virtual Enterprise (MOVE) architecture unifies wired and wireless infrastructures into one seamless network access solution for traveling business professionals, remote workers, corporate headquarters employees and guests. Aruba’s MOVE architecture provides context-aware networking for the post-desktop personal computer (PC) era.
Has ARUN Found The Bottom And Ready To Gain Momentum? Find Out Here
ZIOPHARM Oncology Inc.(NASDAQ:ZIOP) started its trading session with the price of $4.34 and closed at $4.20 by losing -3.23%. ZIOP stocks traded with total volume of 1.01 million shares, while the average trading volume remained 1.18 million shares. The beta of ZIOP stands at 1.60. Day range of the stock was $4.12 -$4.38. ZIOPHARM Oncology, Inc., is a biotechnology company. The Company employs gene expression and control technology to deliver deoxyribonucleic acid (DNA) for the treatment of cancer.
Why Should Investors Buy ZIOP After the Recent Fall? Just Go Here and Find Out
Select Medical Holdings Corporation(NYSE:SEM) ended its day with the loss of -3.19% and closed at the price of $11.24 after opening at $11.63. Stock traded during its last trading session with the total volume of 1.07 million shares, as compared to its average volume of 1.31 million shares. Select Medical Holdings Corporation is an operator of both specialty hospitals and outpatient rehabilitation clinics in the United States. It also provides medical rehabilitation services on a contract basis at nursing homes, hospitals, assisted living and senior care centers, schools and worksites.
Will SEM Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)